| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 06/06/2002 | WO2002043762A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | WO2002043739A2 Dermatological formulations containing clindamycin and a zinc-salt |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/05/2002 | EP1211241A1 Prostaglandin e analogues |
| 06/05/2002 | EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/05/2002 | EP1121112B1 Stable formoterol concentrate |
| 06/05/2002 | CN1352640A Mutual prodrugs of amlodipine and atorvastatin |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 05/30/2002 | US20020065305 As antitumor agent |
| 05/30/2002 | US20020065304 As antitumor agent |
| 05/29/2002 | CN1351608A B-methyl-erythromycin derivatives |
| 05/29/2002 | CN1351606A Halo derivatives of 9-Deoxo-9a-Aza-9a-Homery theromycin A |
| 05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
| 05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
| 05/29/2002 | CN1351499A Composition pharmaceutique |
| 05/23/2002 | US20020061917 Efficient process for the preparation of a factor Xa inhibitor |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | CN1350540A Process for preparing amine platinum complexes |
| 05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/16/2002 | WO2001074341A3 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 05/16/2002 | US20020058618 Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor |
| 05/16/2002 | US20020058617 Effective for reducing body mass and for treating obesity-related diseases and disorderssuch as hyperlipidemias, atherosclerosis, diabetes, and hypertension. |
| 05/16/2002 | US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/15/2002 | EP1204663A1 Novel spiro compounds |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | CN1349415A Contraceptive compositions contaiing antiprogesting and progestinic |
| 05/15/2002 | CN1349404A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity |
| 05/14/2002 | US6388077 Spiro compounds |
| 05/14/2002 | US6387925 Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2001092282A3 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | US20020051800 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 05/02/2002 | EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 05/02/2002 | EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/01/2002 | CN1347324A Composition for treatment of psoriasis |
| 05/01/2002 | CN1347320A Use of cholesterol-lowering agent |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/24/2002 | EP1198237A1 Herbal compositions for itchy or infected skin |
| 04/17/2002 | EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES |
| 04/17/2002 | EP1152755B1 Essential fatty acids in the prevention of cardiovascular events |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/10/2002 | EP1194404A1 Inhibitors of aspartyl protease |
| 04/09/2002 | US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa |
| 04/09/2002 | US6369085 Form of S-omeprazole |
| 04/03/2002 | EP1192125A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/03/2002 | CN1343120A Essential fatty acids in prevention of cardiovascular events |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024690A2 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | WO2002024225A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | CA2424576A1 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | CA2422863A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/27/2002 | CN1342091A Combinations of cardiovascular indications |
| 03/27/2002 | CN1342090A Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular disease |
| 03/21/2002 | WO2002022168A2 Vaccine against streptococcus pneumoniae |
| 03/21/2002 | WO2002022167A2 Vaccine against streptococcus penumoniae |
| 03/21/2002 | WO2002022164A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | CA2422575A1 Composition comprising immunogenic microparticles |
| 03/21/2002 | CA2422002A1 Vaccine |
| 03/21/2002 | CA2421998A1 Vaccine against streptococcus pneumoniae |
| 03/20/2002 | EP1187834A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341019A Antitumour synergistic composition |
| 03/19/2002 | US6359154 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-hydroxy-10-deacetyl baccatin iii; anticarcinogenic agents |
| 03/19/2002 | US6358937 Administering phosphatidic acid and lipid to treat drug abuse, addiction, or withdrawal and/or alcoholism |
| 03/14/2002 | WO2001055130A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 03/14/2002 | US20020032205 An alkyl amine substituted isobenzofuran compound useful for certain psychiatric and neurological disorders; potently binding to the 5-HT1A receptor |
| 03/13/2002 | EP1185274A1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1339967A Composition for treatinb obesity and aesthetic treating method |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/06/2002 | CN1338937A Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 03/06/2002 | CN1338936A Drug-combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | DE10040700A1 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung Salts of biologically active peptides, their preparation and use |
| 02/27/2002 | EP1181294A1 Novel derivatives and analogues of galanthamin |
| 02/27/2002 | EP1181289A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
| 02/27/2002 | EP1181027A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 02/27/2002 | CN1337964A Novel aralkyl amines of spirofuropyridines useful in therapy |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/21/2002 | WO2002014347A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |